Authors
Latest:
Guest Commentary: Health Care Crossroads—Where Do We Go from Here?Chronic disease is the primary driver of health care costs. A focus on coordinated, patient-centered care initiatives will help lessen its impact on patients and pocketbooks.
Latest:
Immunizations and Health Disparities: Immunizations Provided Across a Diverse PopulationVaccines help contain the spread of diseases and reduce morbidity and mortality.
Latest:
What’s All the Fuss? Core Versus Enhanced ServicesCore services are basic to specialty pharmacy offerings, while enhanced services are only provided with payment from a third party, usually a drug manufacturer.
Latest:
Speed-to-Therapy Insights in Specialty PharmacyIt is important to measure speed-to-therapy for specialty drugs to evaluate how much time it takes manufacturers, physicians, insurance companies, hubs, and specialty pharmacies to get essential medications to patients.
Latest:
Specialty Pharmacies Improve Patient Outcomes, Minimize Costs to Health Care SystemThe goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.
Latest:
Help Patients Safely Handle Medications to Improve AdherenceAddressing barriers such as cognitive impairment, cultural issues, and denial can help patients avoid adverse effects.
Latest:
Parenteral Nutrition: Complications of Long-Term Use in Pediatric PatientsCholestasis is a serious complication of long-term parenteral nutrition use.
Latest:
Drug-Induced Liver Injury in Children: Atomoxetine and Nonstimulants for ADHDMechanisms of drug-induced liver injury in children, case reports of atomoxetine-induced liver injury in children, and nonstimulant options for attention-deficit/hyperactivity disorder.
Latest:
Effective Communication Can Make or Break Your BusinessA guide to promoting effective communication among your pharmacy technicians.
Latest:
Impact of New Antihypertensives on Healthcare Utilization by Hypertensive PatientsThe authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.
Latest:
How to Address Bleeding Reversal in Synthetic Cannabinoid UsersThe CDC and local poison control centers offer useful guidance for best practices.
Latest:
Patient Characteristics' Effect on the Conversion Between Basal InsulinsThe characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Antibiotics Are Overprescribed for Pink EyeRecent study results indicate that antibiotic eye drops, despite being ineffective against viral infections and unnecessary for bacterial ones, are often prescribed for patients with acute conjunctivitis.
Latest:
Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B ProgramFailure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.
Latest:
Help Patients Obtain HIV MedicationsLearn how retail or specialty pharmacy distribution can affect access to these important drugs.
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
Pharmacists Can Help Reduce Risk from Extended-Release Acetaminophen --- A Key Potential Confounding Factor in Suspected OverdosesAcetaminophen-related overdose continues to be a leading cause of emergency deparment visits and hospitalizations and remains the leading cause of drug-induced acute liver failure in the United States.
Latest:
Claims Data Analysis of Dosing and Cost of TNF AntagonistHigher drug costs may be attributable to either high initial doses or a dose increase.
Latest:
Fighting the Stigma Around Mental IllnessWhat are you doing to stop the stigma surrounding mental illnesses?
Latest:
Evolutions in Outpatient Cancer CareWithin the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.
Latest:
Healthcare Utilization and Costs for Insured Patients With FibromyalgiaFibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
